Emission of Ultraviolet Radiation from 220 to 280 NM by a Cold Physical Plasma Generating Device

被引:4
作者
Kletschkus, Karsten [1 ]
Gelbrich, Nadine [1 ]
Burchardt, Martin [1 ]
Kramer, Axel [2 ]
Bekeschus, Sander [3 ]
Stope, Matthias B. [1 ]
机构
[1] Univ Med Greifswald, Dept Urol, Plasma Oncol Lab, Greifswald, Germany
[2] Univ Med Greifswald, Inst Hyg & Environm Med, Greifswald, Germany
[3] Leibniz Inst Plasma Sci & Technol INP Greifswald, ZIK Plasmatis, Greifswald, Germany
来源
HEALTH PHYSICS | 2020年 / 119卷 / 01期
关键词
emissions; atmospheric; medical radiation; radiation; non-ionizing; ultraviolet radiation; ATMOSPHERIC ARGON PLASMA; CHRONIC WOUNDS;
D O I
10.1097/HP.0000000000001276
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The generation of cold physical plasma at atmospheric pressure (cold atmospheric plasma: CAP) generates different reactive molecular species as well as radiation in the ultraviolet (UV) range. The therapy of tumor diseases has proven to be a new promising area of application for CAP treatment. With regard to the routine use of CAP in cancer therapy, however, application safety must be ensured both for the patient and for the operator. In this study, the intensity of UVC radiation of the CAP device MiniJet-R (HF Technik, Aachen, Germany) was measured in the range from 220 to 280 nm depending on various device-specific parameters. Depending on the distance to the CAP flame, the UVC intensity reaches values up to 124.5 +/- 11 mW m(-2). It should be noted here that the UVC radiation generated by the CAP is emitted in all orientations in the room but is also shielded by the geometry of the handpiece of the CAP device. The device-specific settings for the flow rate of the carrier gas, argon, and the power level at the high-frequency (HF) generator of the CAP device also influence the intensity of the UVC radiation. With regard to the medical use of the CAP device, it can be stated that there is an exposure to UVC radiation, which, depending on the duration of treatment, can also be above the maximum value legally specified in Europe. Shielding components on the CAP device can reduce UVC exposure to the operator as well as adverse side effects to the patient.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 17 条
[1]  
[Anonymous], 2011, INTENSIVE CARE ME S1, V37, pS6
[2]  
Daeschlein G, 2015, J DTSCH DERMATOL GES, V13, P143, DOI [10.1111/ddg.12559, 10.1111/ddg.12559_suppl]
[3]  
Foest R, 2008, J PHYS D, V41, P194008
[4]  
German Employer's Liability Insurance Association, 2004, 5006102004 BGI
[5]  
Health and Safety Assessment of the Federal Ministry of Labour and Social Affairs, 2014, INK OPT STARHL TECHN
[6]   MELANIN PHOTOSENSITIZES ULTRAVIOLET-LIGHT (UVC) DNA DAMAGE IN PIGMENTED CELLS [J].
HUSELTON, CA ;
HILL, HZ .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1990, 16 (01) :37-43
[7]   Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial [J].
Isbary, G. ;
Heinlin, J. ;
Shimizu, T. ;
Zimmermann, J. L. ;
Morfill, G. ;
Schmidt, H. -U. ;
Monetti, R. ;
Steffes, B. ;
Bunk, W. ;
Li, Y. ;
Klaempfl, T. ;
Karrer, S. ;
Landthaler, M. ;
Stolz, W. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (02) :404-410
[8]   A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients [J].
Isbary, G. ;
Morfill, G. ;
Schmidt, H. U. ;
Georgi, M. ;
Ramrath, K. ;
Heinlin, J. ;
Karrer, S. ;
Landthaler, M. ;
Shimizu, T. ;
Steffes, B. ;
Bunk, W. ;
Monetti, R. ;
Zimmermann, J. L. ;
Pompl, R. ;
Stolz, W. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (01) :78-82
[9]   The antibacterial activity of a microwave argon plasma jet at atmospheric pressure relies mainly on UV-C radiations [J].
Judee, F. ;
Wattieaux, G. ;
Merbahi, N. ;
Mansour, M. ;
Castanie-Cornet, M. P. .
JOURNAL OF PHYSICS D-APPLIED PHYSICS, 2014, 47 (40)
[10]   Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth - A Putative Treatment Option in Ovarian Cancer Therapy [J].
Koensgen, Dominique ;
Besic, Ilma ;
Guembel, Denis ;
Kaul, Anne ;
Weiss, Martin ;
Diesing, Karoline ;
Kramer, Axel ;
Bekeschus, Sander ;
Mustea, Alexander ;
Stope, Matthias B. .
ANTICANCER RESEARCH, 2017, 37 (12) :6739-6744